LAL deficiency

Alexion Pharmaceuticals researches treatments for patients with rare, serious and life-threatening diseases – including LAL deficiency. Our brief was to highlight the treatment of LAL deficiency and persuade doctors to test more patients for the disease.

In disease awareness campaigns, it is common to talk about how a particular disease is detected. We turned this around and chose instead to urge practitioners to rule out LAL deficiency, as it takes no more than a blood sample to determine whether patients are in the risk area. In this way we hope to raise the incentive to do more tests and increase the chances that more patients will be diagnosed. If the doctor can rule out LAL deficiency, that is one disease less to think about in their examination.

We started from the insight that a doctor’s job is like a detective’s, where a process of elimination is used to arrive at the solution. Inspired by the classic thriller “The Usual Suspects”, the other possible diagnoses play the “villains” in the investigation.

Want to find out more about this project? Contact:
Sophia André Klingspor
042-400 48 83
LAL brist Annons
Display For “Swedish Gastro Days”
For “Swedish Gastro Days”
Aimed at doctors who encounter patients with suspected LAL deficiency. The aim was to suggest that LAL deficiency should be ruled out when examining patients for certain diseases.
LAL brist DR vykort 2
LAL brist DR vykort 3
LAL brist rollup
Det senaste inom hälsa, life science och kommunikation.

Följ oss på sociala medier

Relevans Strategi & Kommunikation

Järnvägsgatan 11
Box 1371 , 251 13 Helsingborg
+46 (0)42 400 48 80
Privacy policy